At the recent Association for Value-Based Cancer Care (AVBCC) Education Summit and Program, healthcare professionals and innovators gathered to address the significant challenges posed by disparities between the cost and quality of cancer treatment. It was discussed at AVBCC that these gaps can lead to inefficiencies, delayed care, and unequal access to optimal treatments, which can affect both patients and providers. AVBCC aimed to close these gaps by fostering collaboration and knowledge-sharing among industry stakeholders, policymakers, and decision-makers. Through in-depth discussions, education, and networking, the summit worked toward actionable strategies to improve the efficiency and effectiveness of cancer care.
NantHealth attended the conference to engage with industry partners and discuss the future of healthcare, focusing on the importance of value-based care models. As a leader in healthcare innovation, NantHealth highlighted how its technology platforms support value-based care, particularly in oncology. By leveraging real-time data analytics, clinical decision support systems, care management services, and personalized preferred treatment pathways, NantHealth strives to enable oncologists to optimize care, reduce unnecessary testing, and improve patient outcomes in line with value-based care principles.
A key focus of the conference was the Enhancing Oncology Model (EOM), developed by CMS, aimed at improving care quality while reducing costs for cancer patients. NantHealth has been a strong advocate for the EOM’s goals, aligning its solutions with the model’s emphasis on personalized, patient-centered care. By providing clinicians with access to evidence-based guidelines and clinical pathways, NantHealth plays a vital role in meeting the program’s requirements and enhancing care coordination.
Another highlight was the growing use of AI and automation to streamline oncology care. NantHealth demonstrated how its Eviti Automated Oncology Authorizations tool is transforming clinical decision-making by automating the authorization process. This intelligent, evidence-based platform aims to helps oncology providers make quicker, more accurate decisions, reducing administrative burdens and delays in care.
The AVBCC conference reinforced the critical role of value-based care, AI, and automation in shaping the future of oncology care. NantHealth’s commitment to these innovations positions it at the forefront of efforts to improve cancer care efficiency, affordability, and quality. As the healthcare landscape evolves, NantHealth will continue to drive progress in personalized oncology care, advancing the integration of AI and automation with the goal of achieving better outcomes for patients and a more sustainable healthcare system.